HAL vs PRME · P/E 9.3, $19.05B cap vs rev $3.0M
Halliburton Company (HAL) versus Prime Medicine, Inc. Common Stock (PRME) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported PRME revenue for 2024-12-31 was $3.0M. Net income was -$195.9M. PRME currently screens at market cap $570.8M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. PRME currently screens at market cap $570.8M.
Not investment advice. Open the HAL and PRME stock pages for the full models.
Not investment advice.